Utility of Serum Biomarkers in Diagnosing Fracture-Related Infections: A Pilot Study
R
Roman Natoli, MD
Primary Investigator
Overview
The primary aim will be to determine if serum inflammatory biomarkers can reliably diagnose FRIs as compared to a standardized definition of FRI.
Eligibility
You may be eligible for this study if you meet the following criteria:
-
Conditions:
extremity fracture, pelvic ring fracture, acetabulum fracture
-
Age: Between 18 Years - 85 Years
-
Gender: All
Inclusion Criteria
Fracture Related Infection group
•18 to 85 years old (inclusive) with an extremity, pelvic ring, or acetabulum fracture surgically treated with retained orthopaedic implant within the last two years
•Clinically suspected fracture-related infection
Control group
•18 to 85 years old (inclusive) with an extremity, pelvic ring, or acetabulum fracture surgically treated with retained orthopaedic implant within the last two years matched to the fracture-related infection group
•Patient undergoing index nonunion surgery
•18 to 85 years old (inclusive) with an extremity, pelvic ring, or acetabulum fracture surgically treated with retained orthopaedic implant within the last two years
•Clinically suspected fracture-related infection
Control group
•18 to 85 years old (inclusive) with an extremity, pelvic ring, or acetabulum fracture surgically treated with retained orthopaedic implant within the last two years matched to the fracture-related infection group
•Patient undergoing index nonunion surgery
Updated on
26 Apr 2024.
Study ID: 1905884760
Please visit our main page to search for other studies you may be interested in.
If you need help finding a study or have any questions, please contact us at inhealth@iu.edu
